ENTRADA THERAPEUTICS INC (TRDA) Institutional Ownership Changes & 13F Activity
ENTRADA THERAPEUTICS INC (TRDA). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q1 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Longaeva Partners L.P., Tcg Crossover Management, Llc, Price T Rowe Associates Inc, Nantahala Capital Management, Llc, and Algert Global Llc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Mirae Asset Global Investments Co., Ltd. | Buy | +140 | +7.5% | 1,997 | $25.20K | Q1 2026 | Aug 12, 2026 |
| Algert Global Llc | Sell | -128,611 | -100.0% | 0 | $0.00 | Q1 2026 | Aug 11, 2026 |
| Wells Fargo & Company/Mn | Sell | -21,152 | -65.8% | 11,011 | $138.96K | Q1 2026 | Jul 08, 2026 |
| Adar1 Capital Management, Llc | Buy | +30,500 | — | 30,500 | $384.91K | Q1 2026 | May 18, 2026 |
| Bank Of America Corp | Sell | -26,767 | -40.6% | 39,212 | $494.86K | Q1 2026 | May 18, 2026 |
| California State Teachers Retirement System | Sell | -213 | -12.2% | 1,540 | $19.43K | Q1 2026 | May 18, 2026 |
| Longaeva Partners L.P. | Buy | +204,978 | — | 204,978 | $2.59M | Q1 2026 | May 15, 2026 |
| Tcg Crossover Management, Llc | Buy | +199,108 | +9.5% | 2,287,500 | $28.87M | Q1 2026 | May 15, 2026 |
| Price T Rowe Associates Inc | Buy | +198,620 | +60.7% | 526,043 | $6.64M | Q1 2026 | May 15, 2026 |
| Nantahala Capital Management, Llc | Buy | +159,332 | — | 159,332 | $2.01M | Q1 2026 | May 15, 2026 |
| Acuta Capital Partners, Llc | Buy | +89,358 | — | 89,358 | $1.13M | Q1 2026 | May 15, 2026 |
| Qube Research & Technologies Ltd | Sell | -88,565 | -50.3% | 87,453 | $1.10M | Q1 2026 | May 15, 2026 |
| Morgan Stanley | Sell | -84,125 | -32.3% | 176,126 | $2.22M | Q1 2026 | May 15, 2026 |
| Citadel Advisors Llc | Sell | -77,752 | -26.6% | 215,018 | $2.71M | Q1 2026 | May 15, 2026 |
| Woodline Partners Lp | Buy | +73,867 | +52.0% | 215,977 | $2.73M | Q1 2026 | May 15, 2026 |
| Aqr Capital Management Llc | Buy | +53,239 | +202.8% | 79,493 | $1.00M | Q1 2026 | May 15, 2026 |
| Trexquant Investment Lp | Sell | -38,547 | -31.8% | 82,733 | $1.04M | Q1 2026 | May 15, 2026 |
| Barclays Plc | Sell | -38,471 | -57.3% | 28,676 | $361.89K | Q1 2026 | May 15, 2026 |
| Marshall Wace, Llp | Buy | +33,107 | +160.3% | 53,764 | $678.50K | Q1 2026 | May 15, 2026 |
| Jacobs Levy Equity Management, Inc | Sell | -28,872 | -8.0% | 333,914 | $4.21M | Q1 2026 | May 15, 2026 |
| Geode Capital Management, Llc | Buy | +27,400 | +4.3% | 667,347 | $8.42M | Q1 2026 | May 15, 2026 |
| State Street Corp | Buy | +25,009 | +4.9% | 533,798 | $6.74M | Q1 2026 | May 15, 2026 |
| Millennium Management Llc | Buy | +21,661 | +4.4% | 519,356 | $6.55M | Q1 2026 | May 15, 2026 |
| Brevan Howard Capital Management Lp | Sell | -21,618 | -45.1% | 26,349 | $332.52K | Q1 2026 | May 15, 2026 |
| Shay Capital Llc | Buy | +21,548 | — | 21,548 | $271.94K | Q1 2026 | May 15, 2026 |
| Bridgeway Capital Management, Llc | Sell | -15,000 | -37.5% | 25,000 | $315.50K | Q1 2026 | May 15, 2026 |
| Manufacturers Life Insurance Company, The | Buy | +14,111 | +25.0% | 70,656 | $891.68K | Q1 2026 | May 15, 2026 |
| D. E. Shaw & Co., Inc. | Buy | +12,169 | +18.2% | 79,047 | $997.57K | Q1 2026 | May 15, 2026 |
| Xtx Topco Ltd | Buy | +11,894 | +10.1% | 129,562 | $1.64M | Q1 2026 | May 15, 2026 |
| Cantor Fitzgerald, L. P. | Sell | -10,000 | -17.5% | 47,000 | $593.14K | Q1 2026 | May 15, 2026 |
Frequently asked questions about TRDA activity
Which institutional owners are buying TRDA?
Institutional owners buying TRDA include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in TRDA activity?
"Buy" means an investor increased their reported position in TRDA compared to the prior reporting period. This reflects growing exposure to ENTRADA THERAPEUTICS INC (TRDA) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in TRDA increasing?
Institutional interest in TRDA can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related TRDA Institutional Insights
- TRDA Overview
- TRDA 13F Institutional Holders
- TRDA Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- TRDA Insider Trading & SEC Form 4 Activity
- TRDA Articles
- Top Institutional Investor Stock Rankings